Question 1

How many shares of SNSE does CITADEL ADVISORS LLC own?

Accepted Answer

As of 2026-Q2, CITADEL ADVISORS LLC holds 12,296 shares of SNSE (FAETH THERAPEUTICS INC).

Question 2

What is CITADEL ADVISORS LLC's SNSE position worth?

Accepted Answer

As of 2026-Q2, CITADEL ADVISORS LLC's SNSE position is worth $307,400.

Question 3

Is CITADEL ADVISORS LLC buying or selling SNSE?

Accepted Answer

In 2026-Q2, CITADEL ADVISORS LLC opened a new position in SNSE.

Question 4

When did CITADEL ADVISORS LLC first buy SNSE?

Accepted Answer

Based on available 13F filings, CITADEL ADVISORS LLC first reported a position in SNSE in 2021-Q1. They have held the position across 13 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	New	12,296	-	$307,400	0.0%	$13.85	36
2025-Q1	Exited	0	-100.0%	$0	0.0%	$10.16	0
2024-Q4	Decreased	57,717	-12.6%	$28,287	0.0%	$9.70	0
2024-Q3	Increased	66,044	+329.8%	$39,495	0.0%	$11.12	22
2024-Q2	Decreased	15,366	-35.6%	$9,528	0.0%	$12.40	0
2024-Q1	Decreased	23,864	-7.5%	$25,058	0.0%	$21.00	0
2023-Q4	New	25,803	-	$17,856	0.0%	$13.84	28
2022-Q3	Exited	0	-100.0%	$0	0.0%	$31.80	0
2022-Q2	New	59,380	-	$134,000	0.0%	$44.80	34
2021-Q4	Exited	0	-100.0%	$0	0.0%	$111.40	0
2021-Q3	Decreased	123,258	-56.5%	$1.3M	0.0%	$216.80	0
2021-Q2	Decreased	283,667	-59.0%	$2.8M	0.0%	$182.00	0
2021-Q1	New	692,537	-	$10.1M	0.0%	$246.00	38

SNSE13 quarters

SNSE
13 quarters